Discovery and structure–activity analysis of selective estrogen receptor modulators via similarity-based virtual screening

European Journal of Medicinal Chemistry
2012.0

Abstract

A number of selective estrogen receptor modulators (SERMs) were discovered from the SPECS database via a simple protocol. Based on two reference SERMs we identified via structure-based virtual screening previously, ligand-based similarity search and molecular docking filtering were conducted to identify novel SERMs from SPECS library. Among the 36 purchased compounds, 21 were confirmed to be active by in vitro assays, and 10 showed dual profile properties, namely as antagonists of ERα and agonists of ERβ. The anti-proliferative potency of these ligands was also evaluated against MCF-7 cell lines. Further investigation of the anti-proliferative mechanism of compound 3a suggested that it induced a G1 cell cycle arrest in ERα positive MCF-7 cell through ERα mediated cyclin D1 down-regulation.

Knowledge Graph

Similar Paper

Discovery and structure–activity analysis of selective estrogen receptor modulators via similarity-based virtual screening
European Journal of Medicinal Chemistry 2012.0
Discovery of Potent Ligands for Estrogen Receptor β by Structure-Based Virtual Screening
Journal of Medicinal Chemistry 2010.0
Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ERα and ERβ Activity
Journal of Medicinal Chemistry 2018.0
Discovery of natural estrogen receptor modulators with structure-based virtual screening
Bioorganic & Medicinal Chemistry Letters 2013.0
Design, synthesis and evaluation of Ospemifene analogs as anti-breast cancer agents
European Journal of Medicinal Chemistry 2014.0
Identification and Structure−Activity Relationships of Chromene-Derived Selective Estrogen Receptor Modulators for Treatment of Postmenopausal Symptoms
Journal of Medicinal Chemistry 2009.0
Lead identification of a potent benzopyranone selective estrogen receptor modulator
Bioorganic & Medicinal Chemistry Letters 2004.0
Design, synthesis, biological evaluation and molecular docking studies of novel 3-aryl-4-anilino-2 H -chromen-2-one derivatives targeting ERα as anti-breast cancer agents
Bioorganic & Medicinal Chemistry Letters 2017.0
Synthesis, biological evaluation, structural–activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators
Bioorganic & Medicinal Chemistry 2008.0
Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs
Bioorganic & Medicinal Chemistry Letters 2004.0